Abstract
Objectives
Community pharmacies play a crucial role in China’s primary health care system. This study aimed to assess the impact of stringent COVID-19 policy responses - such as lockdowns, travel restrictions and operational closures - on unannounced standardized patients’ (USPs) satisfaction with community pharmacy services.
Methods
A cross-sectional study was conducted from April 2021 to September 2022, using an USPs approach in community pharmacies across China. USPs’ satisfaction was measured using validated tools, with closure policies related to COVID-19 as the primary exposure variable.
Results
The study included 1076 eligible USP visits to community pharmacies. Results indicated that stricter closure policies had a significant negative impact on USPs’ satisfaction (β = −0.18, p = 0.019). This negative effect may be attributed to worsened capability of pharmaceutical service providers (β = −0.17, p = 0.002) and accessibility (β = −0.12, p = 0.019). Subgroup analyses demonstrated a negative correlation between stricter closure policies and lower satisfaction levels with regard to accessibility, capability, and communication.
Conclusions
COVID-19 closure policies in China had adverse consequences for the quality of pharmacy services. These findings highlight that governments must act with urgency when addressing abrupt infectious diseases or public health emergencies. Enhancing access to pharmacy services and capability of providers are critical strategies to ensure an effective response to sudden public health crises.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
